Director/PDMR Shareholding

General Electric Company
12 May 2023
 


4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden

hours per response:

0.5

  

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person*

Strazik Scott


(Last)

(First)

(Middle)

GENERAL ELECTRIC COMPANY

5 NECCO STREET


(Street)

BOSTON

MA

02210


(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
GENERAL ELECTRIC CO [ GE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)


Director


10% Owner

X

Officer (give title below)


Other (specify below)

Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
05/10/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X

Form filed by One Reporting Person


Form filed by More than One Reporting Person

Rule 10b5-1(c) Transaction Indication

  

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)

2. Transaction Date (Month/Day/Year)

2A. Deemed Execution Date, if any (Month/Day/Year)

3. Transaction Code (Instr. 8)

4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)

5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)

6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

7. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

Amount

(A) or (D)

Price

Common Stock

05/10/2023


M


31,848

A

$0

52,301

D


Common Stock

05/10/2023


M


19,902

A

$0

72,203

D


Common Stock

05/10/2023


M


76,731

A

$0

148,934

D


Common Stock

05/10/2023


M


29,746

A

$0

178,680

D


Common Stock

05/10/2023


M


9,334

A

$0

188,014

D


Common Stock

05/10/2023


M


41,908

A

$0

229,922

D


Common Stock

05/10/2023


S


173,873

D

$99.56(1)

56,049

D


Common Stock








9,580

I

401(k)

Common Stock








5,239

I

Spouse's 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option (right to buy)

$88.41

05/10/2023


M



31,848

(2)

03/19/2028

Common Stock

31,848

$0

0

D


Employee Stock Option (right to buy)

$88.41

05/10/2023


M



19,902

(2)

03/19/2028

Common Stock

19,902

$0

0

D


Employee Stock Option (right to buy)

$46.59

05/10/2023


M



76,731

(3)

12/21/2028

Common Stock

76,731

$0

0

D


Employee Stock Option (right to buy)

$66.59

05/10/2023


M



29,746

(3)

03/19/2029

Common Stock

29,746

$0

0

D


Employee Stock Option (right to buy)

$59.6

05/10/2023


M



9,334

(3)

04/11/2029

Common Stock

9,334

$0

0

D


Employee Stock Option (right to buy)

$73.25

05/10/2023


M



41,908

(3)

03/02/2030

Common Stock

41,908

$0

0

D


Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $99.27 to $99.85, inclusive, in order to cover the option exercise price and relevant taxes . The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

2. The Employee Stock Options became exercisable in three equal installments, each on the first, second and third anniversary of the grant date.

3. The Employee Stock Options became exercisable in two equal installments, each on the second and third anniversary of the grant date.

Remarks:



/s/ Brandon Smith, attorney in fact for Scott Strazik

05/12/2023


** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings